<abstract xml:lang="en" xmlns="http://www.w3.org/1999/xhtml"><p>The present study is aimed to develop dextromethorphan hydrobromide (DXM) oral disintegrating tablets (ODT) with acceptable palatability to help patients of all age groups. The bitter taste of the drug was masked by binding the drug to ion exchange resin. The effect of the particle size of resin on drug loading was studied. <italic>In vitro</italic> and <italic>in vivo</italic> disintegration time and <italic>in vitro</italic> drug release studies were performed. Drug loading increased significantly with a decrease in the particle size of the resin. DSC and XRPD studies reveal that the molecular state of the drug changed from crystalline to amorphous form. The dissolution efficiency calculated for optimized ODT and conventional directly compressed tablet were almost comparable, indicating free dissociation of the drug from the resinate. The bitter taste of DXM can be masked by binding with ion exchange resin and the resinate can be successfully formulated into oral disintegrating tablets.</p></abstract>

The present study is aimed to develop dextromethorphan hydrobromide (DXM) oral disintegrating tablets (ODT) with acceptable palatability to help patients of all age groups. The bitter taste of the drug was masked by binding the drug to ion exchange resin. The effect of the particle size of resin on drug loading was studied. In vitro and in vivo disintegration time and in vitro drug release studies were performed. Drug loading increased significantly with a decrease in the particle size of the resin. DSC and XRPD studies reveal that the molecular state of the drug changed from crystalline to amorphous form. The dissolution efficiency calculated for optimized ODT and conventional directly compressed tablet were almost comparable, indicating free dissociation of the drug from the resinate. The bitter taste of DXM can be masked by binding with ion exchange resin and the resinate can be successfully formulated into oral disintegrating tablets.

Design and evaluation of taste masked dextromethorphan hydrobromide oral disintegrating tablets

CPS Formulations, DR. Reddy's Laboratories Limited, Bachupally Hyderabad-500090, India

Department of Pharmaceutics, St. Peter's Institute of Pharmaceutical Sciences, Vidyanagar, Hanamkonda Warangal-506001, India

Acta Pharmaceutica

The present study is aimed to develop dextromethorphan hydrobromide (DXM) oral disintegrating tablets (ODT) with acceptable palatability to help patients of...

Design and evaluation of taste masked dextromethorphan hydrobromide oral disintegrating tablets

Publicado en línea: 06 dic 2010

Páginas: 267 - 280

DOI: https://doi.org/10.2478/v10007-010-0025-8

Palabras clave
dekstrometorfan hidrobromid, ionsko-izmjenjivačka smola, maskiranje okusa, sredstvo za raspadanje

This content is open access.

Design and evaluation of taste masked dextromethorphan hydrobromide oral disintegrating tablets

Publicado en línea: 06 dic 2010

Páginas: 267 - 280

DOI: https://doi.org/10.2478/v10007-010-0025-8

Palabras clavedekstrometorfan hidrobromid, ionsko-izmjenjivačka smola, maskiranje okusa, sredstvo za raspadanje

This content is open access.

Palabras clave
dekstrometorfan hidrobromid, ionsko-izmjenjivačka smola, maskiranje okusa, sredstvo za raspadanje